[Pathological Risk Stratification of Non-Muscle-Invasive and Muscle-Invasive Urothelial Carcinoma for Optimal Therapeutic Decision-Making].

The treatment of urothelial carcinoma is undergoing rapid change. For both non-muscle-invasive urothelial carcinoma (NMIBC) and muscle-invasive urothelial carcinoma (MIBC), state-of-the-art substances are being tested in various therapy concepts to r…

Preview only. Read the full abstract at the source